JULIE LAWATSCH: Open Payments
NPI 1699928770 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,467 in 136 payments from 22 companies in 2025. Trend: 2023 $893 · 2024 $1,536 · 2025 $2,467
Food & beverage: $2,437Education: $30
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 39 | $604 |
| ABBVIE INC. | 17 | $280 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $185 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $178 |
| Ardelyx, Inc. | 7 | $167 |
| Ipsen Biopharmaceuticals, Inc | 5 | $129 |
| Ferring Pharmaceuticals Inc. | 4 | $128 |
| Regeneron Healthcare Solutions, Inc. | 5 | $126 |
| Madrigal Pharmaceuticals | 2 | $84 |
| Lilly USA, LLC | 5 | $80 |
Products named: TREMFYA, IBSRELA, RINVOQ, XIFAXAN, DUPIXENT, ENTYVIO, IQIRVO, REBYOTA.
Industry payments across NY — which companies pay providers there.
